Literature DB >> 25351463

Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus.

Qijin Wang1, Xiao Zhai, Xiao Chen, Jiancan Lu, Yaping Zhang, Qin Huang.   

Abstract

Type 2 diabetes mellitus (T2DM) is characterized by a chronic low-grade inflammatory state. Follicular helper T cells (Tfh) play critical roles in inducing B-cell activation and producing various cytokines, whereas circulating CD4+CXCR5+ T cells (CTfh) may act as a counterpart to measure Tfh cell disorders. In this study, we investigated whether Tfh could be involved in the development of T2DM by assessing CTfh in peripheral blood. CTfh and it subtypes were determined by measuring CD3, CD4, CXCR5, CXCR3, and CCR6 in 68 T2DM patients and 60 healthy controls using flow cytometry. Results showed that proportion of CTfh in the peripheral CD4+ T cells was significantly increased in T2DM patients (8.5 ± 0.5%) than in controls (4.5 ± 0.3%) (p < 0.001). Further study revealed that the balance of CTfh subtypes was greatly dysregulated, in which percentage of Th17 subtype was significantly increased in patients. Investigating the correlation between CTfh and risk factors of T2DM demonstrated that proportion of CTfh were significantly elevated in patients with body mass index (BMI) over 24.0 (p = 0.005). Interestingly, patients with abdominal obesity had further increase in CTfh than those without abdominal obesity. This study suggests the involvement of CTfh in T2DM, especially in T2DM-related obesity.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD4+CXCR5+ T cells; Circulating; obesity; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 25351463     DOI: 10.1111/apm.12330

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

Review 1.  Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance.

Authors:  Melissa Hui Yen Chng; Michael N Alonso; Sarah E Barnes; Khoa D Nguyen; Edgar G Engleman
Journal:  Mediators Inflamm       Date:  2015-06-04       Impact factor: 4.711

Review 2.  Regulators of Tfh Cell Differentiation.

Authors:  Gajendra M Jogdand; Suchitra Mohanty; Satish Devadas
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

3.  Publication trends of research on diabetes mellitus and T cells (1997-2016): A 20-year bibliometric study.

Authors:  Ye Gao; Yiran Wang; Xiao Zhai; Yifei He; Rong Chen; Jingjing Zhou; Ming Li; Qijin Wang
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

4.  Unlike PD-L1, PD-1 Is Downregulated on Partial Immune Cells in Type 2 Diabetes.

Authors:  Peng Sun; Qingyan Jin; Shengnan Nie; Shijie Jia; Yuanyuan Li; Xiaoxue Li; Fang Guo
Journal:  J Diabetes Res       Date:  2019-03-17       Impact factor: 4.011

5.  Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.

Authors:  Peng Zhang; Chun-Lin Yang; Tong Du; Yu-Dong Liu; Meng-Ru Ge; Heng Li; Ru-Tao Liu; Cong-Cong Wang; Ying-Chun Dou; Rui-Sheng Duan
Journal:  J Neuroinflammation       Date:  2021-10-26       Impact factor: 8.322

6.  A nine-hub-gene signature of metabolic syndrome identified using machine learning algorithms and integrated bioinformatics.

Authors:  Guanzhi Liu; Sen Luo; Yutian Lei; Jianhua Wu; Zhuo Huang; Kunzheng Wang; Pei Yang; Xin Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases.

Authors:  Siwen Zhang; Xiaokun Gang; Shuo Yang; Mengzhao Cui; Lin Sun; Zhuo Li; Guixia Wang
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

8.  Autoantibodies against β1-adrenoceptor induce blood glucose enhancement and insulin insufficient via T lymphocytes.

Authors:  Yulin Gong; Haiyan Xiong; Yunhui Du; Ye Wu; Suli Zhang; Xiao Li; Huirong Liu
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

9.  Integrative analysis of super enhancer SNPs for type 2 diabetes.

Authors:  Weiping Sun; Sihong Yao; Jielong Tang; Shuai Liu; Juan Chen; Daqing Deng; Chunping Zeng
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

10.  T cell immunoglobulin and mucin domain-containing molecule 3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus.

Authors:  Wen-Jiang Yan; Peng Sun; Dan-Dan Wei; Shuang-Xi Wang; Jing-Jing Yang; Yi-Hui Li; Cheng Zhang
Journal:  J Diabetes Investig       Date:  2016-09-30       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.